Hospital Nossa Senhora da Conceicao ( Site 0203)

Porto Alegre, Rio Grande do Sul 91350-200

0 studies enrolling now · 2 studies all time

What they study most

Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Triple Negative Breast Neoplasms

Studies at this site

• Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) — Completed
• Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) — Completed